» Articles » PMID: 12452429

In the Cellular Garden of Forking Paths: How P38 MAPKs Signal for Downstream Assistance

Overview
Journal Biol Chem
Specialty Biochemistry
Date 2002 Nov 28
PMID 12452429
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Mitogen-activated protein kinases (MAPKs) are evolutionarily conserved enzymes which connect cell-surface receptors to regulatory targets within cells and convert receptor signals into various outputs. In mammalian cells, four distinct MAPKs have been identified: the extracellular signal-related kinases (ERK)-1/2, the c-jun N-terminal kinases or stress-activated protein kinases 1 (JNK1/2/3, or SAPK1s), the p38 MAPKs (p38 alpha/beta/gamma/delta, or SAPK2s), and the ERK5 or big MAP kinase 1 (BMK1). The p38 MAPK cascade is activated by stress or cytokines and leads to phosphorylation of its central elements, the p38 MAPKs. Downstream of p38 MAPKs there is a diversification and extensive branching of signalling pathways. For that reason, we will focus in this review on the different signalling events that are triggered by p38 activity, and analyse how these events contribute to specific gene expression and cellular responses.

Citing Articles

p38 Molecular Targeting for Next-Generation Multiple Myeloma Therapy.

Morales-Martinez M, Vega M Cancers (Basel). 2024; 16(2).

PMID: 38254747 PMC: 10813990. DOI: 10.3390/cancers16020256.


A novel small molecule inhibitor of p38⍺ MAP kinase augments cardiomyocyte cell cycle entry in response to direct cell cycle stimulation.

Abouleisa R, Miller J, Gebreil A, Salama A, Dwenger M, Abdelhafez H Br J Pharmacol. 2023; 180(24):3271-3289.

PMID: 37547998 PMC: 10726296. DOI: 10.1111/bph.16209.


Interleukin-6 and pulmonary hypertension: from physiopathology to therapy.

Xu W, Wu Q, He W, Wang S, Zhao Y, Huang J Front Immunol. 2023; 14:1181987.

PMID: 37449201 PMC: 10337993. DOI: 10.3389/fimmu.2023.1181987.


MKK4 Inhibitors-Recent Development Status and Therapeutic Potential.

Katzengruber L, Sander P, Laufer S Int J Mol Sci. 2023; 24(8).

PMID: 37108658 PMC: 10144091. DOI: 10.3390/ijms24087495.


Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2.

Wang G, Wang J, Chang A, Cheng D, Huang S, Wu D Oncogene. 2020; 39(47):7034-7050.

PMID: 32989258 PMC: 7680376. DOI: 10.1038/s41388-020-01481-y.